Gennex Laboratories logo

Gennex Laboratories financials: balance sheet, profit and loss, cash flow

BSE: 531739Pharmaceuticals & BiotechnologySmall Cap

Gennex Laboratories Ltd · Face value ₹1 · Listed May 1996
Last close ₹9.10up ₹0.22 (2.48%)

Share price at the BSE close on 28 Oct 2026. Previous close ₹8.88.

28 Oct: open ₹8.80, high ₹9.21, low ₹8.80

52-week range of traded prices to 28 Oct 2026
₹7.05Low, 30 Mar 2026₹17.25High, 28 Oct 2025
Market cap
₹221 Cr2,248th largest listed
P/E
12.03
P/B
0.99
Dividend yield
Nonein the last 12 months
ROE
9.0%
ROCE
7.0%
Debt to equity
0.15
Volume, BSE
2,86,354

Gennex Laboratories' financial statements for the 10 years to Mar 2026, standalone: the listed company alone, without its subsidiaries, with the twelve months to Jun 2026 after them.

10 years at a glance

₹ crore, years to March.Gennex Laboratories annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
422.7Mar 17440.8Mar 18562.24.5Mar 19561.9Mar 20604.07.4Mar 21613.910Mar 22654.61.0Mar 2367120.8Mar 2495141.2Mar 251201623Mar 26

Operating and net margin, per cent

  • Operating margin
  • Net margin
18.6%1.9%10.8%7.2%5.8%11.0%8.8%7.0%18.6%10.8%11.3%6.5%1.9%4.0%3.3%6.8%6.4%7.0%17.7%14.8%13.5%Mar 17Mar 19Mar 21Mar 23Mar 25Mar 26

The years either side of a change of basis do not compare. From the year to Mar 2018, the company's revenue for that year, ₹44 Cr, differs from its quarters added, ₹47 Cr.

Results for the year to Mar 2026

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue120
  2. Materials and goods−88
  3. Employee costs−6.7
  4. Other expenses−12
  5. Operating profit14
  6. Depreciation−1.0
  7. Other income+8.1
  8. One-off items0.0
  9. Finance costs−2.5
  10. Profit before tax18
  11. Tax−2.1
  12. Net profit16

What the company owns

  • Plant, investments and other assets₹146 Cr
  • Cash and bank₹52 Cr
  • Inventory₹42 Cr
  • Receivables₹33 Cr

What pays for it: net worth and liabilities

  • Net worth₹218 Cr
  • Borrowings₹23 Cr
  • Other liabilities₹17 Cr
  • Owed to suppliers₹16 Cr

Profit and loss

Standalone, ₹ crore, years to March. The last column is the twelve months to Jun 2026, the latest four quarters added.Gennex Laboratories quarterly results

₹ croreMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Filed 31 MayMar 2024Mar 2025Mar 2026Filed 30 MayJun 2026Twelve monthsFiled 14 Aug
Revenue from operations424456566061656795120129
37–52525356615484106115
Materials and goods bought2427333436384038668897
Employee costs5–6–7786676
Other expenses8–13–10111310111212
Operating profit before depreciation5–4375512101413
Operating margin10.8%–7.2%5.8%11.0%8.8%7.0%18.6%10.8%11.3%10.4%
Materials, % of revenue57.1%–58.6%–59.9%62.2%61.3%57.5%70.3%73.0%75.4%
Employee costs, % of revenue11.8%–11.0%–12.1%11.4%11.8%9.1%6.8%5.6%5.0%
Other expenses, % of revenue20.3%–23.2%–17.1%17.6%19.8%14.8%12.1%10.1%9.2%
Depreciation and amortisation11111111111
Operating profit after depreciation4–326541291312
Other income01111134988
Finance costs1–111111222
Profit before one-off items and tax313255615171818
One-off items–0000000000
Profit before tax313355615171818
01111113322
Net profit312244512141616
Other comprehensive income––0–0000000
Total comprehensive income––2–44512141616
Net margin6.5%1.9%4.0%3.3%6.8%6.4%7.0%17.7%14.8%13.5%12.4%
Materials, employee costs and other expenses are shown for the years they add up to operating expenses; for the year to Mar 2020 they do not, so they are left blank. Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the year to Mar 2018: the statement does not state its finance costs, which operating profit is worked out from, so operating profit is not given.

Balance sheet

Standalone, ₹ crore, at 31 March.

₹ croreMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Filed 31 MayMar 2024Mar 2025Mar 2026Filed 30 May
34–404479171185218
Share capital13–131318232324
Reserves21–273161148162194
Borrowings5–71011123
17–192416332952
1–001244
Total assets52–596896205218274
23–212124263136
29–384772179187238
Net debt1–62−13−60−54−30
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Mar 2017, Mar 2018 and Mar 2020, so its lines and the ratios worked from it are blank there.

Cash flow

Standalone, ₹ crore, years to March.

₹ croreMar 2021Mar 2022Mar 2023Filed 31 MayMar 2024Mar 2025Mar 2026Filed 30 May
−1.46.6−14.5−33.4−9.6−40.2
0.17.7−14.5−32.4−6.6−38.1
−6.5−0.1−19.8−45.4−17.6−52.7
Receivables−2.7−2.42.5−4.71.7−21.5
Inventories2.4−2.7−7.2−1.1−8.5−17.0
Payables−3.92.2−1.27.9−3.54.8
Other working capital−2.42.8−13.8−47.4−7.3−19.0
Tax paid−1.5−1.10.0−1.1−3.0−2.1
Capital spending0.10.42.22.86.05.5
Free cash flow−1.56.2−16.7−36.3−15.5−45.7
0.0−1.3−0.80.92.61.6
1.61.921.479.01.535.4
Dividends paid0.00.00.00.00.00.0
Shares bought back0.00.00.00.00.00.0
Shares issued0.00.030.479.80.017.1
Net change in cash0.27.26.146.5−5.4−3.2
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2017, Mar 2018, Mar 2019 and Mar 2020.

Per share

Standalone, ₹ per share, years to March.

₹ per shareMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Filed 31 MayMar 2024Mar 2025Mar 2026Filed 30 May
Earnings per share₹0.21₹0.07₹0.18₹0.15₹0.32₹0.33₹0.26₹0.70₹0.62₹0.67
Diluted earnings per share₹0.21₹0.07₹0.18₹0.15₹0.32₹0.33₹0.26₹0.64₹0.61₹0.67
Book value per share––₹2.69–₹3.15₹3.48₹4.47₹7.51₹8.12₹8.98
Shareholder yield––––0.0%0.0%−30.3%−22.2%0.0%−9.9%
Market cap at the year end (₹ crore)614739244995100359274173

Ratios

Standalone, years to March.Gennex Laboratories PE ratio and valuation

RatioMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Filed 31 MayMar 2024Mar 2025Mar 2026Filed 30 May
Revenue growth––27.5%−0.3%7.2%2.6%6.3%2.6%41.6%26.7%
Operating profit growth–––−19.3%101.2%−17.7%−14.8%171.0%−17.9%32.7%
Net profit growth–−69.1%165.6%−16.4%117.6%−2.8%16.2%158.8%19.0%14.9%
Earnings per share growth–−69.2%166.7%−14.8%112.7%1.9%−20.0%168.5%−11.2%8.1%
––6.5%–10.1%9.4%7.4%9.4%7.9%8.0%
–––––−0.8 pts−1.9 pts2.0 pts−1.6 pts0.1 pts
From the net margin–––––−0.5 pts0.9 pts11.3 pts−1.5 pts−0.7 pts
From asset turnover–––––−0.5 pts−1.8 pts−8.2 pts0.1 pts0.7 pts
From borrowing–––––0.2 pts−1.0 pts−1.0 pts−0.1 pts0.2 pts
Return on capital employed––7.9%–12.0%8.5%4.8%6.8%5.1%5.2%
Cash conversion––––−35.6%169.2%−317.0%−283.3%−68.1%−249.1%
Interest cover5.2–3.83.07.65.23.110.05.95.1
Debt to equity––0.13–0.180.230.010.010.010.10
Receivable days––68–5567497446102
Inventory days––59–5174137153135174
Payable days––91–6174591366065
Cash conversion cycle, days––36–456712790121210
Working capital days––86–153148240470400476
Asset turnover––1.07–1.010.960.790.440.450.49
Assets per rupee of net worth––1.53–1.481.521.341.211.191.22
Sales per rupee of plant––3.57–4.224.474.294.224.815.54
Capital spending to depreciation––––0.090.492.993.517.745.70
Plant being built, % of plant in use––––0.0%0.0%–8.7%13.4%23.9%
Revenue growth is left blank for the year to Mar 2018: between the two periods the company restated its earlier figures, so the two are on different bases and the change is not worked out. No balance sheet is on record for the years to Mar 2017, Mar 2018 and Mar 2020, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2026.

Return on assets, latest year
6.6%
Cash from operations against operating profit
−297.0%
Measure10 years5 years3 years
Revenue growth, yearly rate–15.0%22.6%
Profit growth, yearly rate–31.9%52.4%
Return on equity, average–8.4%8.4%
Return on capital employed, average–6.1%5.7%
Operating margin, average10.1%11.3%13.6%
Net margin, average8.2%11.9%15.3%
Asset turnover, average–0.630.46
Cash conversion cycle, days, average–123141
Interest cover, average5.55.97.0
Debt to equity, average–0.070.04

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations−91−83−40
Cash from investing352
Cash from financing13911635
Capital spending17146
Dividends paid000
Shares bought back000
Shares issued for cash1279717
Borrowings raised292522
Borrowings repaid1111

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Effective tax ratePublished threshold 17.16 per cent12.80–––––––––
A threshold marked as ours has no published figure; it is the line we read the check against.